[Publication Report] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” Report (March 29, 2024)
date : 4/1/2024
Tags: Dementia
![[Publication Report] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” Report (March 29, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20231212-top-1-1.png)
Health and Global Policy Institute (HGPI) has published the report of the online public symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” held on Tuesday, December 12, 2023.
As dementia risk becomes more connected to the individual, this symposium was held to provide an opportunity to consider how civil society should respond to the individualization of risk and what actions should be taken as a whole in order to build an inclusive society.
The symposium introduced ethical issues, the latest studies, and initiatives for dementia risk, including examples from overseas. We shared methods of approaching risks with society from the perspectives of industry, Government, academia, and civil society. In “dementia risk reduction, “we discussed who is it referring to when it says “those who want to (prevent dementia)” as specified in Article 21 of the Dementia Basic Act for Inclusive Society, and the significance of what is included in the Dementia Basic Act. We also deepen discussion on the need for and promotion of industry-academia/public-private collaboration, including how to utilize private sector technologies, products, and services in future dementia prevention efforts.
Based on the report of this symposium, we hope that the discussion on “dementia risk reduction” will be further deepened by domestic and international stakeholders.
[Event Overview]
- Date & Time: Tuesday, December 12, 2023; 17:00 – 20:30 JST
- Format: Online (Zoom Webinars)
- Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Host: Health and Global Policy Institute
- Sponsor:
Integra LifeSciences Corporation.
Splink,Inc.
Sompo Holdings, Inc.
National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
[Programme] (Titles omitted; in Japanese syllabary order)
17:00-17:05 | Opening remarks |
Hayato Suzuki (Member, House of Representatives / Executive Director, Parliamentary Association for Promoting Dementia Policies for an Inclusive Society) |
|
17:05-17:10 | Explanatory introduction |
Shunichiro Kurita (Senior Manager, HGPI) | |
Part1 | |
17:10-17:35 | Keynote lecture: Ethical Issues on the Individualization of Dementia Risk |
Shingo Segawa (Project coordinator and Researcher, Department of Medical Ethics and History of Medicine, University Medical Center Göttingen) | |
17:35-18:05 | Presentations: The Frontlines of Dementia Risk |
Building Evidence through Multifactorial Interventions Developing Communities to Foster Longevity |
|
Part 2 | |
18:10-19:20 | Presentations: Preparing for Dementia Risk as a Society |
From the perspective of industry: Necessary Steps to Develop Brain Health From the perspective of industry: Building and Providing a Comprehensive Support Package From the perspective of academia: Preventing Severe Complications Using Robots and Industry-Academia Collaboration From the perspective of academia: Transitioning from Individual Disease Prevention to Community-Building From the perspective of academia: A Form of Dementia that Improves with Treatment and Building Early Detection System From the perspective of civil society: Civil Society-Led Action to Prepare as a Society From the perspective of government: Improving Dementia in the *Me-Byo Stage |
|
19:30-20:30 | Discussion: How to Bear the Costs of Prevention and Health Promotion as a Society |
Panelists: Moderator: |
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)